A Randomized, Open-Label, Assessor-Blinded, Split-Face Study of Imiquimod 5% Cream Applied After Cryotherapy of Actinic Keratoses.
Phase of Trial: Phase IV
Latest Information Update: 10 Nov 2016
At a glance
- Drugs Imiquimod (Primary)
- Indications Actinic keratosis; Skin cancer
- Focus Therapeutic Use
- 15 Nov 2010 Company added in the association field and additional lead trial centre identified as reported by ClinicalTrials.gov.
- 26 Mar 2010 Actual patient number (27) added as reported by ClinicalTrials.gov.
- 26 Mar 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.